A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels–Alder Click Chemistry
Brian M. Zeglis,Kuntal K. Sevak,Thomas Reiner,Priya Mohindra,Sean Carlin,Pat Zanzonico,Ralph Weissleder,Jason S. Lewis +7 more
TLDR
The development of a methodology for pretargeted PET imaging based on the bioorthogonal Diels–Alder click reaction between tetrazine and transcyclooctene and the high quality of the images produced by this pretargeting approach is reported, marking this system as a strong candidate for clinical translation.Abstract:
The specificity of antibodies have made immunoconjugates promising vectors for the delivery of radioisotopes to cancer cells; however, their long pharmacologic half-lives necessitate the use of radioisotopes with long physical half-lives, a combination that leads to high radiation doses to patients. Therefore, the development of targeting modalities that harness the advantages of antibodies without their pharmacokinetic limitations is desirable. To this end, we report the development of a methodology for pretargeted PET imaging based on the bioorthogonal Diels–Alder click reaction between tetrazine and transcyclooctene. Methods: A proof-of-concept system based on the A33 antibody, SW1222 colorectal cancer cells, and 64Cu was used. The huA33 antibody was covalently modified with transcyclooctene, and a NOTA-modified tetrazine was synthesized and radiolabeled with 64Cu. Pretargeted in vivo biodistribution and PET imaging experiments were performed with athymic nude mice bearing A33 antigen–expressing, SW1222 colorectal cancer xenografts. Results: The huA33 antibody was modified with transcyclooctene to produce a conjugate with high immunoreactivity, and the 64Cu-NOTA–labeled tetrazine ligand was synthesized with greater than 99% purity and a specific activity of 9–10 MBq/μg. For in vivo experiments, mice bearing SW1222 xenografts were injected with transcyclooctene-modified A33; after allowing 24 h for accumulation of the antibody in the tumor, the mice were injected with 64Cu-NOTA–labeled tetrazine for PET imaging and biodistribution experiments. At 12 h after injection, the retention of uptake in the tumor (4.1 ± 0.3 percent injected dose per gram), coupled with the fecal excretion of excess radioligand, produced images with high tumor-to-background ratios. PET imaging and biodistribution experiments performed using A33 directly labeled with either 64Cu or 89Zr revealed that although absolute tumor uptake was higher with the directly radiolabeled antibodies, the pretargeted system yielded comparable images and tumor-to-muscle ratios at 12 and 24 h after injection. Further, dosimetry calculations revealed that the 64Cu pretargeting system resulted in only a fraction of the absorbed background dose of A33 directly labeled with 89Zr (0.0124 mSv/MBq vs. 0.4162 mSv/MBq, respectively). Conclusion: The high quality of the images produced by this pretargeting approach, combined with the ability of the methodology to dramatically reduce nontarget radiation doses to patients, marks this system as a strong candidate for clinical translation.read more
Citations
More filters
Journal ArticleDOI
Matching chelators to radiometals for radiopharmaceuticals.
TL;DR: This article is a guide for selecting the optimal match between chelator and radiometal for use in these systems, and a large selection of the most common and most promising chelators are evaluated and discussed for their potential use with a variety of radiometals.
Journal ArticleDOI
Inverse electron demand Diels–Alder reactions in chemical biology
TL;DR: The exceptional fast kinetics of this catalyst-free reaction, even using low concentrations of coupling partners, make it amenable for in vivo radiolabelling using pretargeting methodologies, which are discussed.
Journal ArticleDOI
Site-selective protein-modification chemistry for basic biology and drug development
Nikolaus Krall,Filipa P. da Cruz,Omar Boutureira,Gonçalo J. L. Bernardes,Gonçalo J. L. Bernardes +4 more
TL;DR: The most exciting current and future applications of chemical site-selective protein modification are highlighted and which hurdles still need to be overcome for more widespread use are considered.
Journal ArticleDOI
The Future of Bioorthogonal Chemistry.
TL;DR: An outlook on the future of bioorthogonal chemistry is presented and currently emerging opportunities and speculate on how bioorthogsonal reactions might be applied in research and translational settings are discussed.
Journal ArticleDOI
Click to release: instantaneous doxorubicin elimination upon tetrazine ligation.
TL;DR: The fastest click reaction, the highly selective inverse-electron-demand Diels-Alder reaction, has been modified to enable selective bioorthogonal release and caused the instantaneous release of a tetrazine with a drug-bound trans-cyclooctene.
References
More filters
Journal ArticleDOI
Click Chemistry: Diverse Chemical Function from a Few Good Reactions.
TL;DR: In this paper, a set of powerful, highly reliable, and selective reactions for the rapid synthesis of useful new compounds and combinatorial libraries through heteroatom links (C-X-C), an approach called click chemistry is defined, enabled, and constrained by a handful of nearly perfect "springloaded" reactions.
Journal ArticleDOI
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
TL;DR: The bioorthogonal chemical reactions developed to date are described and how they can be used to study biomolecules.
Journal Article
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.
TL;DR: The extensive testing of the OLINDA/EXM code, based on comparison with literature-established dose calculations and with the widely tested and accepted MIRDOSE3.1 code, should give users confidence in its output, and should be easy for MIRDose users to adopt and for new users to understand.
Journal ArticleDOI
Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity.
TL;DR: A bioorthogonal reaction that proceeds with unusually fast reaction rates without need for catalysis: the cycloaddition of s-tetrazine and trans-cyclooctene derivatives, which enables protein modification at low concentration.
Journal ArticleDOI
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium and Zirconium for PET and SPECT Imaging of Disease
TL;DR: SPECT and PET technology has been around for decades, but its use remained limited because of the limited availability of relevant isotopes which had to be produced in nuclear reactors or particle accelerators, but the introduction of the small biomedical cyclotron, the self-contained radionuclide generator and the dedicated small animal or clinical SPECT andPET scanners to hospitals and research facilities has increased the demand for SPect and PET isotopes.